(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
10 day averaged volume of Blueprint Medicines is 644250
| Date | Daily Closing Price | Open | High | Low | Volume |
| 20 Wed Nov 2024 | 94.81 | 94.16 | 95.02 | 92.66 | 0.879 times |
| 19 Tue Nov 2024 | 94.60 | 89.69 | 95.48 | 88.97 | 1.209 times |
| 18 Mon Nov 2024 | 90.18 | 88.43 | 90.66 | 88.05 | 0.975 times |
| 15 Fri Nov 2024 | 88.69 | 96.34 | 96.34 | 88.41 | 1.554 times |
| 14 Thu Nov 2024 | 95.65 | 99.18 | 100.01 | 95.46 | 0.732 times |
| 13 Wed Nov 2024 | 96.88 | 98.00 | 100.23 | 96.83 | 0.569 times |
| 12 Tue Nov 2024 | 96.62 | 98.60 | 100.85 | 96.52 | 0.702 times |
| 11 Mon Nov 2024 | 99.87 | 102.07 | 103.55 | 99.41 | 0.707 times |
| 08 Fri Nov 2024 | 100.83 | 101.58 | 101.97 | 98.95 | 0.97 times |
| 07 Thu Nov 2024 | 101.39 | 99.33 | 102.47 | 98.59 | 1.083 times |
My analysis of stock is bullish for shortterm, and stock might move up till 98.6 or till 106. Use a stoploss of 92.39 and if this stock hits its stoploss, then it can fall down till 86.22
Share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Target | 80.68 |
| Downside Target | 83.91 |
| Downside Target | 87.24 |
| Upside Target | 94.98 |
| Upside Target | 95.48 |
| Upside Target | 96.50 |
| Upside Target | 102.47 |
| Upside Target | 103.55 |
| Upside Target | 106.56 |
| Upside Target | 108.40 |
| Upside Target | 121.90 |
Intraday share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Intraday Target | 90.08 |
| Downside Intraday Target | 85.35 |
| Upside Intraday Target | 97.51 |
| Upside Intraday Target | 100.21 |
| Downside Intraday Target | 92.78 |
Weekly technical analysis of Blueprint Medicines (BPMC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 20 Wed Nov 2024 | 94.81 | 88.43 | 95.48 | 88.05 | 0.719 times |
| 15 Fri Nov 2024 | 88.69 | 102.07 | 103.55 | 88.41 | 0.721 times |
| 08 Fri Nov 2024 | 100.83 | 90.70 | 102.47 | 89.50 | 0.733 times |
| 01 Fri Nov 2024 | 90.70 | 83.33 | 94.98 | 80.68 | 1.761 times |
| 25 Fri Oct 2024 | 82.47 | 85.78 | 87.24 | 81.22 | 1.174 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 20 Wed Nov 2024 | 94.81 | 87.53 | 103.55 | 87.28 | 0.63 times |
| 31 Thu Oct 2024 | 87.51 | 91.63 | 94.98 | 80.68 | 1.055 times |
| 30 Mon Sep 2024 | 92.50 | 94.80 | 96.50 | 83.91 | 0.853 times |
| 30 Fri Aug 2024 | 95.54 | 106.51 | 108.40 | 89.35 | 1.157 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Blueprint Medicines in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 95.38 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Blueprint Medicines in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 95.38 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.